Approval · Notice of Compliance 12637 · 2011
TENORETIC: Notice of Compliance 12637
Issued September 14, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12637
- Date
- September 14, 2011
- Company
- Astrazeneca Canada IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New Manufacturing Site for the Drug Product
- Therapeutic class
- Antihypertensive Agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TENORETIC | Not yet assigned | — |
Medicinal ingredients
- ATENOLOL 50 MG per TAB
- CHLORTHALIDONE 25 MG per TAB
- ATENOLOL 100 MG per TAB